Search alternatives:
026 decrease » nn decrease (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
_ decrease » _ decreased (Expand Search)
m decrease » _ decreased (Expand Search), _ decreases (Expand Search), a decreased (Expand Search)
_ 026 » _ 2026 (Expand Search), _ 26 (Expand Search), _ 02 (Expand Search)
12 m » 12 mm (Expand Search), 12 mg (Expand Search), 12 _ (Expand Search)
026 decrease » nn decrease (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
_ decrease » _ decreased (Expand Search)
m decrease » _ decreased (Expand Search), _ decreases (Expand Search), a decreased (Expand Search)
_ 026 » _ 2026 (Expand Search), _ 26 (Expand Search), _ 02 (Expand Search)
12 m » 12 mm (Expand Search), 12 mg (Expand Search), 12 _ (Expand Search)
-
1
HRMECs treated with SUZ12 siRNA demonstrate increased miR-200b expression, decreased VEGF expression and decreased endothelial branching.
Published 2015“…[NG+control siRNA = 5mM D-glucose + 100nM control siRNA, HG+control siRNA = 25mM D-glucose + 100nM control siRNA, HG+EZH2 siRNA = 25mM D-glucose + 100nM EZH2 siRNA, HG+SUZ12 siRNA = 25mM + 100nM SUZ12 siRNA; identical letters represent groups that are not significantly different; p < 0.05; n = 6; data expressed as mean ± SEM, normalized to U6 or β-actin and expressed as a fold change of NG+control siRNA].…”
-
2
-
3
GCase activity is significantly decreased in the brain and liver of the homozygous <i>GBA1</i> D409V KI mouse model at 4, 8, and 12 months of age.
Published 2021“…In whole brain homogenate (A,C) and liver homogenate (B,D), GCase activity is significantly decreased in the <i>GBA1</i> D409V KI homozygous (HOM) mice as compared to C57Bl/6 wild type (WT) mice (n = 7/group). …”
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
Emodin decreases proteinuria and fibronectin secretion in diabetic rats.
Published 2014“…Emodin can significantly decrease elevated proteinuria by diabetes. (<b>c, d</b>) GFR and blood glucose was measured 6–12 h before sacrifice. …”
-
14
-
15
-
16
Characterization of the optimized nanoparticles (These values are means of a minimum of 5 batches).
Published 2015Subjects: -
17
TEM images of (a) amlodipine (b) hydrochlorothiazide and (c) candesartan nanoparticles.
Published 2015Subjects: -
18
FT-IR spectra of (a) amlodipine (b) hydrochlorohiazide and (c) candesartan nanoparticles.
Published 2015Subjects: -
19
PK profile of: (a) The developed NanoFDC and (b) Combination of the free candidate drugs.
Published 2015Subjects: -
20